EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Outcome of neonatal jaundice in term neonates with ABO blood group incompatibility admitted to the special care baby unit of Khyber Teaching Hospital

Sumaira Naz, Sheema Gul, Hira Tahir, Sadiq Amin, Khan Salam, Jan Muhammad Afridi

International Journal of Pathology · 16.07.2026 · 24 (2) · 138-147

DOI: 10.59736/ijp.24.02.1092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pathology, online erschienen am 16.07.2026. Verfasst von Sumaira Naz und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neonatal jaundice is a common condition affecting newborns worldwide, with more than 50% of term and up to 80% of preterm infants developing hyperbilirubinemia. Although most cases are physiological, ABO blood group incompatibility is an important pathological cause resulting from maternal anti-A or anti-B antibodies crossing the placenta and causing hemolysis of fetal red blood cells. Affected neonates may develop early-onset jaundice, anemia, reticulocytosis, and severe hyperbilirubinemia, which can lead to bilirubin encephalopathy if not treated promptly. This study was conducted to evaluate the clinical outcomes, treatment interventions, and complications among term neonates with ABO incompatibility admitted to Khyber Teaching Hospital.

Methods

This descriptive study was conducted in the Department of Pediatric Medicine, Khyber Teaching Hospital, Peshawar from March 2026 to June 2026. A total of 210 term neonates with confirmed ABO incompatibility were included. Demographic details, laboratory parameters including total serum bilirubin, hemoglobin, reticulocyte count, and direct antiglobulin test (DAT), treatment modalities, complications, and duration of hospital stay were recorded and analyzed.

Results

Phototherapy was required in 150 (71%) neonates, intravenous immunoglobulin (IVIG) was administered to 45 (21%), and exchange transfusion was performed in 20 (9%). Anemia developed in 30 (14%) neonates, while bilirubin encephalopathy occurred in 5 (2%). Inferential analysis demonstrated that DAT-positive neonates were significantly more likely to require IVIG and exchange transfusion and had significantly longer hospital stays than DAT-negative neonates (p < 0.05).

Conclusion

ABO incompatibility remains a significant cause of neonatal jaundice among term infants. Early diagnosis, close monitoring, and timely therapeutic interventions are essential to prevent severe hyperbilirubinemia and associated complications.

Zitieren

APA

Naz, S., Gul, S., Tahir, H., Amin, S., Salam, K., & Afridi, J. M. (2026). Outcome of neonatal jaundice in term neonates with ABO blood group incompatibility admitted to the special care baby unit of Khyber Teaching Hospital. International Journal of Pathology, 24(2), 138-147. https://doi.org/10.59736/ijp.24.02.1092

Vancouver

Naz S, Gul S, Tahir H, Amin S, Salam K, Afridi JM. Outcome of neonatal jaundice in term neonates with ABO blood group incompatibility admitted to the special care baby unit of Khyber Teaching Hospital. International Journal of Pathology. 2026;24(2):138-147. doi:10.59736/ijp.24.02.1092

BibTeX
@article{Naz2026,
  author = {Naz, Sumaira and Gul, Sheema and Tahir, Hira and Amin, Sadiq and Salam, Khan and Afridi, Jan Muhammad},
  title = {Outcome of neonatal jaundice in term neonates with ABO blood group incompatibility admitted to the special care baby unit of Khyber Teaching Hospital},
  journal = {International Journal of Pathology},
  year = {2026},
  volume = {24},
  number = {2},
  pages = {138--147},
  doi = {10.59736/ijp.24.02.1092}
}
Kostenlos starten →